Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06955 BOAN BIOTECH
RT Nominal up9.030 +0.280 (+3.200%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others596,983-2.995%615,417572,092504,842462,170
Land & other Lease Assets10,861-7.115%11,69310,60216,71816,906
Intangible Assets1,139,44319.878%950,504731,505566,002325,266
Interests in Asso. & JCEs0--0000
Other Non-current Assets52,07058.920%32,76541,68579,19211,626

1,799,35711.735%1,610,3791,355,8841,166,754815,968
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories177,9827.678%165,291143,63498,84019,672
Trade Receivables346,42425.427%276,195212,124107,267700
Cash & Bank Balances172,124-14.727%201,850233,498531,7033,629
Other Current Assets52,495-24.653%69,671257,419202,04068,061
Assets Held for Sale0--0000

749,0255.052%713,007846,675939,85092,062
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables237,2119.026%217,572160,203138,71491,585
S-T Debt & Leases179,8634.934%171,40691,72320,0197,647
Other Current Liabilities138,552-47.592%264,371219,745101,749296,945
Liab asso w/ Assets Held for Sale0--0000

555,626-14.957%653,349471,671260,482396,177
Net Current Assets193,399224.179%59,658375,004679,368(304,115)
Total Assets Less Current Liabilities1,992,75619.324%1,670,0371,730,8881,846,122511,853
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases482,384105.708%234,499210,000244,5048,486
Other Non-current Liabilities118,6142.545%115,670102,51149,93121,778

600,99871.631%350,169312,511294,43530,264
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital509,2780.000%509,278509,278498,5830
  Reserves882,4808.869%810,590909,0991,053,104481,589
  Others0--0000
Shareholders' Funds1,391,7585.447%1,319,8681,418,3771,551,687481,589
Non-controlling Interests0--0000
Others0--0000

1,391,7585.447%1,319,8681,418,3771,551,687481,589
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----225,008236,353109,03413,256
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 14/11/2024 14:55
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 61,672,000
%Change--
EPS / (LPS)RMB 0.120
NBV Per Share (¥)RMB 2.733
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.